Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: July 05, 2019
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX.
Journal: Pancreas
Published: June 19, 2019
Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy.
Journal: Annals of surgical oncology
Published: September 14, 2018
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 24, 2018
Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.
Journal: Annals of surgery
Published: January 16, 2018
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Journal: Annals of surgical oncology
Published: December 18, 2017
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma.
Journal: Annals of surgery
Published: June 20, 2017
Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.
Journal: Annals of surgical oncology
Published: June 14, 2017
18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 28, 2017
Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: January 24, 2017
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 16, 2016
Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study.
Journal: Advances in radiation oncology
Published: November 15, 2016
Last Updated: 09/26/2026